| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.800 | None | 0.994 | 164 | 7 | 1991 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.600 | None | 0.990 | 199 | 2 | 2003 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.955 | 67 | 4 | 1991 | 2019 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
disease | 0.600 | None | 0.930 | 43 | 1 | 1992 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.590 | None | 1.000 | 10 | 0 | 1988 | 2016 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.560 | None | 1.000 | 7 | 2 | 1988 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.500 | strong | 0.976 | 41 | 0 | 1997 | 2019 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 5 | 0 | 2016 | 2019 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
disease | 0.400 | None | 0.976 | 82 | 0 | 1997 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.977 | 43 | 1 | 2005 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 1.000 | 29 | 2 | 2002 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.400 | None | 1.000 | 22 | 0 | 2000 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.909 | 11 | 0 | 2014 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.380 | None | 1.000 | 9 | 1 | 1998 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 2009 | 2018 | ||||||||
|
nuclear receptor coactivator 4 | 0.619 | 0.577 | 2.2E-06 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1996 | 2015 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.370 | None | 1.000 | 7 | 1 | 2003 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2002 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2003 | 2016 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.350 | None | 0.833 | 6 | 0 | 2009 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.350 | None | 1.000 | 5 | 3 | 2010 | 2017 | ||||||||
|
tropomyosin 3 | 0.490 | 0.808 | 6.7E-03 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
RAP1 GTPase activating protein | 0.626 | 0.500 | 0.84 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2010 | 2012 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.330 | strong | 1.000 | 4 | 0 | 2000 | 2010 |